Gender Affirming Hormone Therapy in Humans

Evidence from Murine Models
Erscheinungsjahr 2025
ISBN: 978-0-443-29252-1
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 191 mm x 235 mm

Gender Affirming Hormone Therapy in Humans: Evidence from Murine Models is an unprecedented reference for scientists, researchers, students and anyone interested in this field of research. The book is a review of the current state of mouse animal models of relevance to transgender health. It's divided into chapters specific for different tissues in which mouse models are described and their relevance to human health is discussed. This is a novel reference summarizing what these models demonstrate about the benefits and risks of GAHT and the most effective and lowest risk approach to treatment. The models suggest applications of this research to human studies and treatment of transgender people. There is an expanding number of transgender people with are few evidence based books that address this field relating to the importance and growing role of murine models.

Autoren/Hrsg.

Zajac, Jeffrey David

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie

Inhaltsverzeichnis

1. Introduction to transgender animal models, advantages and disadvantages and relevance to humans
2. Male to Female and Female to Male models, controls
3. Cross gender hormone effects on bone
4. Cross gender hormone effects on the CVS and blood pressure
5. Cross gender hormone effects on the immune system
6. Cross gender hormone effects on muscle
7. Cross gender hormone effects on body composition
8. Cross gender hormone effects the kidney
9. Cross gender hormone effects on wound healing
10. Cross gender hormone effects on the CNS
11. Conclusion

Über Autor(innen)

Zajac, Jeffrey David
Jeffrey Zajac is Professor and Head of the University of Melbourne and Chair of Department of Medicine at Austin Health. He is a Clinical Endocrinologist and General Physician with research interests in molecular endocrinology.

Professor Zajac trained in Medicine at the University of Melbourne and undertook a PhD. Following postdoctoral work in the Endocrine Genetics Unit at Massachusetts General Hospital, Boston, he returned to the University of Melbourne initially at Royal Melbourne Hospital and now Austin Health. His research group has embarked on a major research program investigating the effect of androgen deprivation therapy in patients with prostate cancer. These investigations include effects on bone, muscle, cardiovascular risk and metabolic state. He also heads a molecular endocrinology group investigating the androgen receptor using genetically modified mice. His clinical interests include general endocrinology, the use, misuse and abuse of testosterone, and transgender medicine.